Log In
Print
BCIQ
Print
Print this Print this
 

UMK-121

  Manage Alerts
Collapse Summary General Information
Company Proteonomix Ltd.
DescriptionCombination of 2 undisclosed, approved drugs used to mobilize stem cells from bone marrow
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLiver disease
Indication DetailsTreat end-stage liver disease (ESLD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today